[ARWR] QoQ Quarter Result on 30-Sep-2023 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
29-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q4]
Profit Trend
QoQ- -6.54%
YoY- -27.62%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 3,551 16,097 15,825 146,267 62,546 -
PBT -173,977 -126,996 -138,689 -108,990 -103,383 47,676 -41,794 158.99%
Tax 0 -1,696 -3,313 2,025 742 -999 17 -
NP -170,793 -125,300 -132,864 -109,679 -102,946 48,675 -41,811 155.75%
Tax Rate - - - - - 2.10% - -
Total Cost 170,793 125,300 136,415 125,776 118,771 97,592 104,357 38.91%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -3,741.59 -681.36 -650.53 33.28 -66.85 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -1.38 -1.02 -1.24 -1.02 -0.96 0.46 -0.39 132.38%
EPS Diluted -1.38 -1.02 -1.24 -1.02 -0.96 0.45 -0.39 132.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.